Lannett Co Inc (LCI): Price and Financial Metrics

Lannett Co Inc (LCI): $0.69

0.03 (+3.86%)

POWR Rating

Component Grades








Add LCI to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals




#86 of 172

in industry

LCI Price/Volume Stats

Current price $0.69 52-week high $3.72
Prev. close $0.66 52-week low $0.64
Day low $0.65 Volume 280,600
Day high $0.72 Avg. volume 92,067
50-day MA $1.79 Dividend yield N/A
200-day MA $2.10 Market Cap 7.38M

LCI Stock Price Chart Interactive Chart >

LCI Stock Summary

  • LCI has a higher market value than only 2.64% of US stocks; more precisely, its current market capitalization is $7,105,934.
  • LCI's price/sales ratio is 0.02; that's higher than the P/S ratio of only 0.33% of US stocks.
  • The volatility of LANNETT CO INC's share price is greater than that of 97.23% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to LCI, based on their financial statements, market capitalization, and price volatility, are ERJ, ELAN, EGO, EMBC, and JMIA.
  • LCI's SEC filings can be seen here. And to visit LANNETT CO INC's official web site, go to

LCI Valuation Summary

  • In comparison to the median Healthcare stock, LCI's price/earnings ratio is 100% lower, now standing at 0.
  • LCI's price/sales ratio has moved down 9 over the prior 243 months.

Below are key valuation metrics over time for LCI.

Stock Date P/S P/B P/E EV/EBIT
LCI 2023-04-17 0 0 0.0 -4.4
LCI 2023-04-14 0 0 0.0 -4.4
LCI 2023-04-13 0 0 0.0 -4.4
LCI 2023-04-12 0 0 0.0 -4.4
LCI 2023-04-11 0 0 0.0 -4.4
LCI 2023-04-10 0 0 -0.1 -4.4

LCI Growth Metrics

    Its 2 year net income to common stockholders growth rate is now at -911.84%.
  • Its 5 year price growth rate is now at -64.74%.
  • Its 3 year net income to common stockholders growth rate is now at -14.62%.
Over the past 15 months, LCI's revenue has gone down $145,305,000.

The table below shows LCI's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 308.519 -51.497 -192.52
2022-09-30 314.133 -35.653 -237.297
2022-06-30 340.579 -7.125 -231.62
2022-03-31 372.399 38.531 -316.211
2021-12-31 406.412 99.284 -288.455
2021-09-30 453.824 90.275 -379.318

LCI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • LCI has a Quality Grade of C, ranking ahead of 38.22% of graded US stocks.
  • LCI's asset turnover comes in at 0.579 -- ranking 62nd of 682 Pharmaceutical Products stocks.
  • AWH, DRRX, and CLSN are the stocks whose asset turnover ratios are most correlated with LCI.

The table below shows LCI's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.579 0.146 -0.243
2021-06-30 0.535 0.158 -0.227
2021-03-31 0.507 0.181 -0.193
2020-12-31 0.502 0.199 -0.198
2020-09-30 0.473 0.272 0.008
2020-06-30 0.470 0.303 0.016

LCI Price Target

For more insight on analysts targets of LCI, see our LCI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.00 Average Broker Recommendation 2 (Hold)

Lannett Co Inc (LCI) Company Bio

Lannett Company develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications. The company was founded in 1942 and is based in Philadelphia, Pennsylvania.

LCI Latest News Stream

Event/Time News Detail
Loading, please wait...

LCI Latest Social Stream

Loading social stream, please wait...

View Full LCI Social Stream

Latest LCI News From Around the Web

Below are the latest news stories about LANNETT CO INC that investors may wish to consider to help them evaluate LCI as an investment opportunity.

Lannett CFO John Kozlowski to step down

  • Lannett (NYSE:LCI) on Friday said its CFO John Kozlowski would depart on May 16.
  • The company said Kozlowski would be "separated without cause" from his position as VP of finance, CFO and principal accounting officer.
  • "The company has in place succession plans for all its key employees and is currently reviewing succession planning alternatives to address the chief financial officer role after (Kozlowski's) departure," LCI said in a regulatory filing.
  • La...

    Seeking Alpha | April 14, 2023


Lannett Company, Inc. (NYSE: LCI) (the "Company") today shared a business update as it focuses on strategically positioning the Company to continue manufacturing and delivering safe, affordable, effective, life-enhancing generic pharmaceutical products for its valued patients and customers.

Yahoo | April 4, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We're beginning the day with a look at the biggest pre-market stock movers traders need to know about for Wednesday morning!

William White on InvestorPlace | March 15, 2023

7 Stocks to Sell as Borrowing Costs Rise

With new economic data boding poorly for risk-on investments, investors should strongly consider targeting stocks to sell.

Josh Enomoto on InvestorPlace | February 28, 2023

Recent uptick might appease Lannett Company, Inc. (NYSE:LCI) institutional owners after losing 26% over the past year

If you want to know who really controls Lannett Company, Inc. ( NYSE:LCI ), then you'll have to look at the makeup of...

Yahoo | February 7, 2023

Read More 'LCI' Stories Here

LCI Price Returns

1-mo N/A
3-mo -67.76%
6-mo -70.84%
1-year -67.64%
3-year -97.69%
5-year -98.97%
YTD -66.88%
2022 -67.85%
2021 -75.15%
2020 -26.08%
2019 77.82%
2018 -78.62%

Continue Researching LCI

Want to see what other sources are saying about Lannett Co Inc's financials and stock price? Try the links below:

Lannett Co Inc (LCI) Stock Price | Nasdaq
Lannett Co Inc (LCI) Stock Quote, History and News - Yahoo Finance
Lannett Co Inc (LCI) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!